In The News Posted April 16, 2019 Share Posted April 16, 2019 NEW YORK, April 15, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased shares of Amyris, Inc. (NASDAQ: AMRS), an industrial biotechnology company that manufactures and sells natural, sustainably-sourced... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.